These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21689662)

  • 1. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrapie prions: a three-dimensional model of an infectious fragment.
    Huang Z; Prusiner SB; Cohen FE
    Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
    Jahandideh S; Jamalan M; Faridounnia M
    J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion propagation and molecular chaperones.
    Zahn R
    Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations.
    Kuznetsov IB; Rackovsky S
    Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion diseases. Yielding under the strain.
    Weissmann C
    Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890
    [No Abstract]   [Full Text] [Related]  

  • 19. Deadly conformations--protein misfolding in prion disease.
    Horwich AL; Weissman JS
    Cell; 1997 May; 89(4):499-510. PubMed ID: 9160742
    [No Abstract]   [Full Text] [Related]  

  • 20. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.